Literature DB >> 23567077

Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation.

Anne Woellmer1, Wolfgang Hammerschmidt.   

Abstract

Epigenetic mechanisms govern the different life phases of Epstein-Barr virus (EBV). In the first prelatent phase the viral DNA acquires nucleosomes, histone marks are established, and 5'-methyl cytosine residues become detectable. In the latent phase repressive histone marks and extensive DNA methylation silence the majority of viral promoters sparing a few latent genes. DNA methylation is a prerequisite for the induction of EBV's lytic phase in order to escape from latency and give rise to viral progeny. All three phases rely on the different epigenetic states of viral DNA and the availability of viral and cellular factors. EBV exploits cellular mechanisms of epigenetic regulation for its different life phases and serves as a marvelous example of an intimate host-pathogen relationship.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23567077      PMCID: PMC3799965          DOI: 10.1016/j.coviro.2013.03.005

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  22 in total

1.  The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome.

Authors:  Prasanna M Bhende; William T Seaman; Henri-Jacques Delecluse; Shannon C Kenney
Journal:  Nat Genet       Date:  2004-09-12       Impact factor: 38.330

2.  The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.

Authors:  Markus Kalla; Christine Göbel; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

3.  Lytic cycle gene regulation of Epstein-Barr virus.

Authors:  Wolfgang Amon; Ulrich K Binné; Helen Bryant; Peter J Jenkins; Claudio Elgueta Karstegl; Paul J Farrell
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells.

Authors:  C Kintner; B Sugden
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

5.  Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.

Authors:  R J Tierney; H E Kirby; J K Nagra; J Desmond; A I Bell; A B Rickinson
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  CTCF prevents the epigenetic drift of EBV latency promoter Qp.

Authors:  Italo Tempera; Andreas Wiedmer; Jayaraju Dheekollu; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

7.  Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.

Authors:  Eri Seto; Andreas Moosmann; Sebastian Grömminger; Nicole Walz; Adam Grundhoff; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

8.  trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.

Authors:  E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  CpG-methylation regulates a class of Epstein-Barr virus promoters.

Authors:  Martin Bergbauer; Markus Kalla; Anne Schmeinck; Christine Göbel; Ulrich Rothbauer; Sebastian Eck; Anna Benet-Pagès; Tim M Strom; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

10.  BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.

Authors:  Anne Woellmer; Jose M Arteaga-Salas; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2012-09-06       Impact factor: 6.823

View more
  32 in total

1.  Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus.

Authors:  Fang Lu; Andreas Wiedmer; Kayla A Martin; Priyankara J M S Wickramasinghe; Andrew V Kossenkov; Paul M Lieberman
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 2.  An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle.

Authors:  Adityarup Chakravorty; Bill Sugden; Eric C Johannsen
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 3.  Epigenetic regulation of EBV persistence and oncogenesis.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Semin Cancer Biol       Date:  2014-01-24       Impact factor: 15.707

Review 4.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

Review 5.  The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.

Authors:  A A Gru; B H Haverkos; A G Freud; J Hastings; N B Nowacki; C Barrionuevo; C E Vigil; R Rochford; Y Natkunam; R A Baiocchi; P Porcu
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

6.  5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.

Authors:  Coral K Wille; Dhananjay M Nawandar; Amanda N Henning; Shidong Ma; Kayla M Oetting; Dennis Lee; Paul Lambert; Eric C Johannsen; Shannon C Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-09       Impact factor: 11.205

Review 7.  Epigenetic crossroads of the Epstein-Barr virus B-cell relationship.

Authors:  Thomas C Frost; Benjamin E Gewurz
Journal:  Curr Opin Virol       Date:  2018-09-15       Impact factor: 7.090

8.  Opinion: Genetic Conflict With Mobile Elements Drives Eukaryotic Genome Evolution, and Perhaps Also Eukaryogenesis.

Authors:  Adena B Collens; Laura A Katz
Journal:  J Hered       Date:  2021-03-12       Impact factor: 2.645

9.  Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma.

Authors:  Paul W Harms; Monique E Verhaegen; Josh N Vo; Jean C Tien; Drew Pratt; Fengyun Su; Saravana M Dhanasekaran; Xuhong Cao; Doris Mangelberger; Julia VanGoor; Jae Eun Choi; Vincent T Ma; Andrzej A Dlugosz; Arul M Chinnaiyan
Journal:  J Invest Dermatol       Date:  2021-08-30       Impact factor: 8.551

Review 10.  Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.

Authors:  Margaret L Gulley
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.